3,4-Dihydroxyhydrocinnamic Acid for Myoblast Growth and Atrophy Control

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

There is a strong demand for a novel material that can prevent muscle atrophy and promote myoblast proliferation, which is highly safe and suitable for use in food, drink, and pharmaceutical products, while existing compositions like those containing theaflavin compounds are limited in effectiveness and safety.

Innovation Solution

A compound represented by Structural Formula (1), such as 3,4-dihydroxyhydrocinnamic acid, is used as an active ingredient in myoblast proliferation promoters and muscle atrophy inhibitors, exhibiting excellent myoblast-proliferation promotion and muscle-atrophy inhibition effects.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing compositions containing theaflavin compounds are used to maintain muscle fibers, then muscle fiber maintenance effect is achieved, but the effectiveness and safety are limited and do not meet the strong demand for novel materials

Engineering Contradiction:

ImprovesafetyVSAvoideffectiveness

Core Design Contradiction:

ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent changes the chemical structure parameter by using 3,4-dihydroxyhydrocinnamic acid instead of theaflavin compounds, achieving both improved safety and effectiveness. The structural modification leads to enhanced myoblast proliferation promotion effect and muscle atrophy inhibition effect while maintaining high safety profile.

Inventive Principle:

Principle #35Parameter changes

2Productivity

If a novel material is developed to prevent muscle atrophy and promote myoblast proliferation, then effectiveness is improved, but safety and suitability for food and pharmaceutical products must be ensured

Engineering Contradiction:

Improvemyoblast proliferation promotion effectVSAvoidsafety

Core Design Contradiction:

ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent employs a naturally occurring compound (3,4-dihydroxyhydrocinnamic acid) that is safe for consumption, making it suitable for food and pharmaceutical applications. The compound's natural origin and safety profile allow it to be used in a wide range of products including food, drinks, and medicines without harmful effects.

Inventive Principle:

Principle #27Cheap short-living objects (Disposable)

Data Source

PatentUS20250302784A1Myoblast proliferation promoter and myoblast-proliferation promoting composition, and muscle atrophy inhibitor and muscle-atrophy inhibiting composition

Publication Date: 2025.10.02 MARUZEN PHARMA

AI summary

A myoblast proliferation promoter and a muscle atrophy inhibitor are provided, each of which includes a compound represented by Structural Formula (1) below,